{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:33:49Z","timestamp":1791146029707,"version":"4.1.0"},"reference-count":82,"publisher":"Japanese Association of Virology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Uirusu"],"published-print":{"date-parts":[[2012]]},"DOI":"10.2222\/jsv.62.9","type":"journal-article","created":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T22:44:40Z","timestamp":1368053080000},"page":"9-18","source":"Crossref","is-referenced-by-count":7,"title":["miRNA in HTLV-1 related Disease"],"prefix":"10.2222","volume":"62","author":[{"given":"Makoto","family":"YAMAGISHI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"WATANABE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1062","reference":[{"key":"1","unstructured":"1)Bartel DP.: MicroRNAs: target recognition and regulatory functions. Cell 136: 215233, 2009."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2)Cullen BR.: Transcription and processing of human microRNA precursors. Mol. Cell 16: 861865, 2004.","DOI":"10.1016\/j.molcel.2004.12.002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3)Friedman RC, Farh KK, Burge CB, Bartel DP.: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19: 92105, 2009.","DOI":"10.1101\/gr.082701.108"},{"key":"4","unstructured":"4)Xiao C, Rajewsky K.: MicroRNA control in the immune system: basic principles. Cell 136: 2636, 2009."},{"key":"5","unstructured":"5)Gangaraju VK, Lin H.: MicroRNAs: key regulators of stem cells. Nat. Rev. Mol. Cell Biol. 10: 116125, 2009."},{"key":"6","unstructured":"6)Ventura A, Jacks T.: MicroRNAs and cancer: short RNAs go a long way. Cell 136: 586591, 2009."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7)Skalsky RL, Cullen BR.: Viruses, microRNAs, and host interactions. Annu. Rev. Microbiol. 64: 123141, 2010.","DOI":"10.1146\/annurev.micro.112408.134243"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8)Lujambio A, Lowe SW.: The microcosmos of cancer. Nature 482: 347355, 2012.","DOI":"10.1038\/nature10888"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9)Pfeffer S, Zavolan M, Grsser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, Tuschl T.: Identification of virus-encoded microRNAs. Science 304: 734736, 2004.","DOI":"10.1126\/science.1096781"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10)Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, Grsser FA, van Dyk LF, Ho CK, Shuman S, Chien M, Russo JJ, Ju J, Randall G, Lindenbach BD, Rice CM, Simon V, Ho DD, Zavolan M, Tuschl T.: Identification of microRNAs of the herpesvirus family. Nat. Methods 2: 269276, 2005.","DOI":"10.1038\/nmeth746"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11)Omoto S, Ito M, Tsutsumi Y, Ichikawa Y, Okuyama H, Brisibe EA, Saksena NK, Fujii YR.: HIV-1 nef suppression by virally encoded microRNA. Retrovirology 1: 44, 2004","DOI":"10.1186\/1742-4690-1-44"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12)Bennasser Y, Le SY, Benkirane M, Jeang KT.: Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22: 607619, 2005.","DOI":"10.1016\/j.immuni.2005.05.004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13)Lin J, Cullen BR.: Analysis of the interaction of primate retroviruses with the human RNA interference machinery. J. Virol. 81: 1221812226, 2007.","DOI":"10.1128\/JVI.01390-07"},{"key":"14","unstructured":"14)Li SC, Shiau CK, Lin WC.: Vir-Mir db: prediction of viral microRNA candidate hairpins. Nucleic Acids Res. 36: D184D189, 2008."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15)Ruggero K, Corradin A, Zanovello P, Amadori A, Bronte V, Ciminale V, D'Agostino DM.: Role of microRNAs in HTLV-1 infection and transformation. Mol. Aspects Med. 31: 367382, 2010.","DOI":"10.1016\/j.mam.2010.05.001"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16)Huang J, Wang F, Argyris E, Chen K, Liang Z, Tian H, Huang W, Squires K, Verlinghieri G, Zhang H.: Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat. Med. 13: 12411247, 2007.","DOI":"10.1038\/nm1639"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17)Wang X, Ye L, Hou W, Zhou Y, Wang YJ, Metzger DS, Ho WZ.: Cellular microRNA expression correlates with susceptibility of monocytes\/macrophages to HIV-1 infection. Blood 113: 671674, 2009.","DOI":"10.1182\/blood-2008-09-175000"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18)Nathans R, Chu CY, Serquina AK, Lu CC, Cao H, Rana TM.: Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol. Cell 34: 696709, 2009.","DOI":"10.1016\/j.molcel.2009.06.003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19)Hakim ST, Alsayari M, McLean DC, Saleem S, Addanki KC, Aggarwal M, Mahalingam K, Bagasra O.: A large number of the human microRNAs target lentiviruses, retroviruses, and endogenous retroviruses. Biochem. Biophys. Res. Commun. 369: 357362, 2008.","DOI":"10.1016\/j.bbrc.2008.02.025"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20)Abe M, Suzuki H, Nishitsuji H, Shida H, Takaku H. Interaction of human T-cell lymphotropic virus type I Rex protein with Dicer suppresses RNAi silencing. FEBS Lett. 584: 43134318, 2010.","DOI":"10.1016\/j.febslet.2010.09.031"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21)Rahman S, Quann K, Pandya D, Singh S, Khan ZK, Jain P.: HTLV-1 Tax Mediated Downregulation of miRNAs Associated with Chromatin Remodeling Factors in T Cells with Stably Integrated Viral Promoter. PLoS One 7: e34490, 2012.","DOI":"10.1371\/journal.pone.0034490"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22)Hall WW, Fujii M.: Deregulation of cell-signaling pathways in HTLV-1 infection. Oncogene 24: 59655975, 2005.","DOI":"10.1038\/sj.onc.1208975"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23)Boxus M, Twizere JC, Legros S, Dewulf JF, Kettmann R, Willems L.: The HTLV-1 Tax interactome. Retrovirology 5: 76, 2008.","DOI":"10.1186\/1742-4690-5-76"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24)Matsuoka M, Jeang KT.: Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 7: 270280, 2007.","DOI":"10.1038\/nrc2111"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25)Ruben S, Poteat H, Tan TH, Kawakami K, Roeder R, Haseltine W, Rosen CA.: Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product. Science 241: 8992, 1988.","DOI":"10.1126\/science.2838905"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26)Yoshida M.: Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu. Rev. Immunol. 19: 475496, 2001.","DOI":"10.1146\/annurev.immunol.19.1.475"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27)Saitoh Y, Yamamoto N, Dewan MZ, Sugimoto H, Martinez Bruyn VJ, Iwasaki Y, Matsubara K, Qi X, Saitoh T, Imoto I, Inazawa J, Utsunomiya A, Watanabe T, Masuda T, Yamamoto N, Yamaoka S.: Overexpressed NF-kappaB-inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells. Blood 111: 51185129, 2008.","DOI":"10.1182\/blood-2007-09-110635"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28)Watanabe M, Ohsugi T, Shoda M, Ishida T, Aizawa S, Maruyama-Nagai M, Utsunomiya A, Koga S, Yamada Y, Kamihira S, Okayama A, Kikuchi H, Uozumi K, Yamaguchi K, Higashihara M, Umezawa K, Watanabe T, Horie R.: Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood 106: 24622471, 2005.","DOI":"10.1182\/blood-2004-09-3646"},{"key":"29","unstructured":"29)Dewan MZ, Terashima K, Taruishi M, Hasegawa H, Ito M, Tanaka Y, Mori N, Sata T, Koyanagi Y, Maeda M, Kubuki Y, Okayama A, Fujii M, Yamamoto N.: Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID\/gammac(null) mice: suppression by an inhibitor against NF-kappaB. J. Virol. 77: 52865294, 2003."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30)Satou Y, Nosaka K, Koya Y, Yasunaga JI, Toyokuni S, Matsuoka M.: Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro. Leukemia 18: 13571363, 2004.","DOI":"10.1038\/sj.leu.2403400"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31)Ohsugi T, Kumasaka T, Ishida A, Ishida T, Horie R, Watanabe T, Umezawa K, Yamaguchi K.: In vitro and in vivo antitumor activity of the NF-kappaB inhibitor DHMEQ in the human T-cell leukemia virus type I-infected cell line, HUT-102. Leuk. Res. 30: 9097, 2006.","DOI":"10.1016\/j.leukres.2005.06.001"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32)Horie R, Watanabe T, Umezawa K.: Blocking NF-kappaB as a potential strategy to treat adult T-cell leukemia\/lymphoma. Drug News Perspect. 19: 201209, 2006.","DOI":"10.1358\/dnp.2006.19.4.985934"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33)Sanda T, Asamitsu K, Ogura H, Iida S, Utsunomiya A, Ueda R, Okamoto T.: Induction of cell death in adult T-cell leukemia cells by a novel IkappaB kinase inhibitor. Leukemia 20: 590598, 2006.","DOI":"10.1038\/sj.leu.2404129"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34)Nishioka C, Ikezoe T, Yang J, Koeffler HP, Taguchi H.: Fludarabine induces apoptosis of human T-cell leukemia virus type 1-infected T cells via inhibition of the nuclear factor-kappaB signal pathway. Leukemia 21: 10441049, 2007.","DOI":"10.1038\/sj.leu.2404622"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35)Uota S, Zahidunnabi Dewan M, Saitoh Y, Muto S, Itai A, Utsunomiya A, Watanabe T, Yamamoto N, Yamaoka S.: An I\u03baB kinase 2 inhibitor IMD-0354 suppresses the survival of adult T-cell leukemia cells. Cancer Sci. 103: 100106, 2012.","DOI":"10.1111\/j.1349-7006.2011.02110.x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36)Annunziata CM, Davis RE, Demchenko Y, Bellamy W, Gabrea A, Zhan F, Lenz G, Hanamura I, Wright G, Xiao W, Dave S, Hurt EM, Tan B, Zhao H, Stephens O, Santra M, Williams DR, Dang L, Barlogie B, Shaughnessy Kuehl WM, Staudt LM.: Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 12: 115130, 2007.","DOI":"10.1016\/j.ccr.2007.07.004"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37)Pham LV, Fu L, Tamayo AT, Bueso-Ramos C, Drakos E, Vega F, Medeiros LJ, Ford RJ.: Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-\u03baB-inducing kinase while activating both canonical and alternative nuclear factor-\u03baB pathways. Blood 117: 200210, 2011.","DOI":"10.1182\/blood-2010-06-290437"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38)Yamamoto M, Ito T, Shimizu T, Ishida T, Semba K, Watanabe S, Yamaguchi N, Inoue JI.: Epigenetic alteration of the NF-kappaB-inducing kinase (NIK) gene is involved in enhanced NIK expression in basal-like breast cancer. Cancer Sci. 101: 23912397, 2010.","DOI":"10.1111\/j.1347-9032.2010.01685.x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39)Thu YM, Su Y, Yang J, Splittgerber R, Na S, Boyd A, Mosse C, Simons C, Richmond A.: NF-\u03baB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the \u03b2-catenin pathway. Oncogene: advance online publication, 2011.","DOI":"10.1158\/1538-7445.AM2011-2889"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40)Sun SC.: Non-canonical NF-\u03baB signaling pathway. Cell Res. 21: 7185, 2011.","DOI":"10.1038\/cr.2010.177"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41)Pichler K, Schneider G, Grassmann R.: MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes. Retrovirology 5: 100, 2008.","DOI":"10.1186\/1742-4690-5-100"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42)Cobb BS, Hertweck A, Smith J, O'Connor E, Graf D, Cook T, Smale ST, Sakaguchi S, Livesey FJ, Fisher AG, Merkenschlager M.: A role for Dicer in immune regulation. J. Exp. Med. 203: 25192527, 2006.","DOI":"10.1084\/jem.20061692"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43)Motsch N, Pfuhl T, Mrazek J, Barth S, Grsser FA.: Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol. 4: 131137, 2007.","DOI":"10.4161\/rna.4.3.5206"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44)Cameron JE, Yin Q, Fewell C, Lacey M, McBride J, Wang X, Lin Z, Schaefer BC, Flemington EK.: Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J. Virol. 82: 19461958, 2008.","DOI":"10.1128\/JVI.02136-07"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45)Yeung ML, Yasunaga J, Bennasser Y, Dusetti N, Harris D, Ahmad N, Matsuoka M, Jeang KT.: Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res. 68: 89768985, 2008.","DOI":"10.1158\/0008-5472.CAN-08-0769"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46)Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J, Garcia S, Nowak J, Yeung ML, Jeang KT, Chaix A, Fazli L, Motoo Y, Wang Q, Rocchi P, Russo A, Gleave M, Dagorn JC, Iovanna JL, Carrier A, Pbusque MJ, Dusetti NJ.: Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc. Natl. Acad. Sci. U S A. 104: 1617016175, 2007.","DOI":"10.1073\/pnas.0703942104"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47)Gommeaux J, Cano C, Garcia S, Gironella M, Pietri S, Culcasi M, Pbusque MJ, Malissen B, Dusetti N, Iovanna J, Carrier A.: Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1. Mol. Cell. Biol. 27: 22152228, 2007.","DOI":"10.1128\/MCB.01454-06"},{"key":"48","unstructured":"48)Ito Y, Motoo Y, Yoshida H, Iovanna JL, Takamura Y, Miya A, Kuma K, Miyauchi A.: Decreased expression of tumor protein p53-induced nuclear protein 1 (TP53INP1) in breast carcinoma. Anticancer Res. 26: 43914395, 2006."},{"key":"49","doi-asserted-by":"crossref","unstructured":"49)Jiang PH, Motoo Y, Garcia S, Iovanna JL, Pebusque MJ, Sawabu N.: Down-expression of tumor protein p53-induced nuclear protein 1 in human gastric cancer. World J. Gastroenterol. 12: 691696, 2006.","DOI":"10.3748\/wjg.v12.i5.691"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50)Bonazzi VF, Irwin D, Hayward NK.: Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma. Genes Chromosomes Cancer 48: 1021, 2009.","DOI":"10.1002\/gcc.20615"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51)Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi JT, Braich R, Manoharan M, Soutschek J, Ohler U, Cullen BR.: A viral microRNA functions as an orthologue of cellular miR-155. Nature 450: 10961099, 2007.","DOI":"10.1038\/nature05992"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52)Thompson RC, Herscovitch M, Zhao I, Ford TJ, Gilmore TD.: NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155\/PU.1 pathway. J. Biol. Chem. 286: 16751682, 2011.","DOI":"10.1074\/jbc.M110.177063"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53)Liu S, Yang Y, Wu J.: TNF\u03b1-induced up-regulation of miR-155 inhibits adipogenesis by down-regulating early adipogenic transcription factors. Biochem. Biophys. Res. Commun. 414: 618624, 2011.","DOI":"10.1016\/j.bbrc.2011.09.131"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54)Bellon M, Lepelletier Y, Hermine O, Nicot C.: Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood 113: 49144917, 2009.","DOI":"10.1182\/blood-2008-11-189845"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55)Chen CZ, Li L, Lodish HF, Bartel DP.: MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 8386, 2004.","DOI":"10.1126\/science.1091903"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56)Lu LF, Liston A.: MicroRNA in the immune system, microRNA as an immune system. Immunology 127: 291298, 2009.","DOI":"10.1111\/j.1365-2567.2009.03092.x"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57)Yamagishi M, Nakano K, Miyake A, Yamochi T, Kagami Y, Tsutsumi A, Matsuda Y, Sato-Otsubo A, Muto S, Utsunomiya A, Yamaguchi K, Uchimaru K, Ogawa S, Watanabe T.: Polycomb-Mediated Loss of miR-31 Activates NIK-Dependent NF-\u03baB Pathway in Adult T Cell Leukemia and Other Cancers. Cancer Cell 21: 121135, 2012.","DOI":"10.1016\/j.ccr.2011.12.015"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58)Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR.: MicroRNA expression profiles classify human cancers. Nature 435: 834838, 2005.","DOI":"10.1038\/nature03702"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59)Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C, Ambros VR, Israel MA.: Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 67: 24562468, 2007.","DOI":"10.1158\/0008-5472.CAN-06-2698"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60)Roush S, Slack FJ.: The let-7 family of microRNAs. Trends Cell Biol. 18: 505516, 2008.","DOI":"10.1016\/j.tcb.2008.07.007"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61)Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B, Laxman B, Cao X, Jing X, Ramnarayanan K, Brenner JC, Yu J, Kim JH, Han B, Tan P, Kumar-Sinha C, Lonigro RJ, Palanisamy N, Maher CA, Chinnaiyan AM.: Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322: 16951699, 2008.","DOI":"10.1126\/science.1165395"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62)Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szsz AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA.: A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137: 10321046, 2009.","DOI":"10.1016\/j.cell.2009.03.047"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63)Valastyan S, Benaich N, Chang A, Reinhardt F, Weinberg RA.: Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis. Genes Dev. 23: 25922597, 2009.","DOI":"10.1101\/gad.1832709"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64)Uribesalgo I, Ballare C, Croce LD.: Polycomb Regulates NF-\u03baB Signaling in Cancer through miRNA. Cancer Cell 21: 57, 2012.","DOI":"10.1016\/j.ccr.2011.12.019"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65)Sparmann A, van Lohuizen M.: Polycomb silencers control cell fate, development and cancer. Nat. Rev. Cancer 6: 846856, 2006.","DOI":"10.1038\/nrc1991"},{"key":"66","unstructured":"66)Simon JA, Kingston RE.: Mechanisms of polycomb gene silencing: knowns and unknowns. Nat. Rev. Mol. Cell Biol. 10: 697708, 2009."},{"key":"67","unstructured":"67)Rouas R, Fayyad-Kazan H, El Zein N, Lewalle P, Roth F, Simion A, Akl H, Mourtada M, El Rifai M, Burny A, Romero P, Martiat P, Badran B.: Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur. J. Immunol. 39: 16081618, 2009."},{"key":"68","doi-asserted-by":"crossref","unstructured":"68)Liu CJ, Tsai MM, Hung PS, Kao SY, Liu TY, Wu KJ, Chiou SH, Lin SC, Chang KW.: miR-31 Ablates Expression of the HIF Regulatory Factor FIH to Activate the HIF Pathway in Head and Neck Carcinoma. Cancer Res. 70: 16351644, 2010.","DOI":"10.1158\/0008-5472.CAN-09-2291"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69)Creighton CJ, Fountain MD, Yu Z, Nagaraja AK, Zhu H, Khan M, Olokpa E, Zariff A, Gunaratne PH, Matzuk MM, Anderson ML.: Molecular Profiling Uncovers a p53-Associated Role for MicroRNA-31 in Inhibiting the Proliferation of Serous Ovarian Carcinomas and Other Cancers. Cancer Res. 70: 19061915, 2010.","DOI":"10.1158\/0008-5472.CAN-09-3875"},{"key":"70","unstructured":"70)Valastyan S, Weinberg RA.: miR-31: A crucial overseer of tumor metastasis and other emerging roles. Cell Cycle 9: 21242129, 2010."},{"key":"71","doi-asserted-by":"crossref","unstructured":"71)Hayden MS, Ghosh S.: Signaling to NF-kappaB. Genes Dev. 18: 21952224, 2004.","DOI":"10.1101\/gad.1228704"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72)Bonizzi G, Karin M.: The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25: 280288, 2004.","DOI":"10.1016\/j.it.2004.03.008"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73)Hayden MS, Ghosh S.: Shared principles in NF-kappaB signaling. Cell 132: 344362, 2008.","DOI":"10.1016\/j.cell.2008.01.020"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74)Manel N, Kim FJ, Kinet S, Taylor N, Sitbon M, Battini JL.: The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115: 449459, 2003.","DOI":"10.1016\/S0092-8674(03)00881-X"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75)Ghez D, Lepelletier Y, Jones KS, Pique C, Hermine O.: Current concepts regarding the HTLV-1 receptor complex. Retrovirology 7: 99, 2010.","DOI":"10.1186\/1742-4690-7-99"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76)Igakura T, Stinchcombe JC, Goon PK, Taylor GP, Weber JN, Griffiths GM, Tanaka Y, Osame M, Bangham CR.: Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 299: 17131716, 2003.","DOI":"10.1126\/science.1080115"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77)Pais-Correia AM, Sachse M, Guadagnini S, Robbiati V, Lasserre R, Gessain A, Gout O, Alcover A, Thoulouze MI.: Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses. Nat. Med. 16: 8389, 2010.","DOI":"10.1038\/nm.2065"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78)Hasegawa H, Sawa H, Lewis MJ, Orba Y, Sheehy N, Yamamoto Y, Ichinohe T, Tsunetsugu-Yokota Y, Katano H, Takahashi H, Matsuda J, Sata T, Kurata T, Nagashima K, Hall WW.: Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat. Med. 12: 466472, 2006.","DOI":"10.1038\/nm1389"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79)Ohsugi T, Kumasaka T, Okada S, Urano T.: The Tax protein of HTLV-1 promotes oncogenesis in not only immature T cells but also mature T cells. Nat. Med. 13: 527528, 2007.","DOI":"10.1038\/nm0507-527"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80)Banerjee P, Tripp A, Lairmore MD, Crawford L, Sieburg M, Ramos JC, Harrington W Jr, Beilke MA, Feuer G.: Adult T-cell leukemia\/lymphoma development in HTLV-1-infected humanized SCID mice. Blood 115: 26402648, 2010.","DOI":"10.1182\/blood-2009-10-246959"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81)Lee RC, Feinbaum RL, Ambros V.: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843854, 1993.","DOI":"10.1016\/0092-8674(93)90529-Y"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82)Wightman B, Ha I, Ruvkun G.: Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75: 855862, 1993.","DOI":"10.1016\/0092-8674(93)90530-4"}],"container-title":["Uirusu"],"original-title":["HTLV-1\u611f\u67d3\u75c7\u3068miRNA"],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T17:41:18Z","timestamp":1621532478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/62\/1\/62_9\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2222\/jsv.62.9","relation":{},"ISSN":["0042-6857"],"issn-type":[{"value":"0042-6857","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}